Every major nation on earth is building DNA infrastructure right now. Billions in public funding. Millions of genomes. Multi-year national programs. The question is not whether genomic identification is coming. It is already here. The only question is whether your nation has the infrastructure to use it.
The EU 1+ Million Genomes (1+MG) initiative is the largest multinational genomic data infrastructure program in history. Signed by 25 EU member states plus the UK and Norway in 2018. The Genomic Data Infrastructure (GDI) project, co-funded under the Digital Europe Programme at EUR 40 million (November 2022 to October 2026), deploys 54 institutional partners across 20 countries. By 2026, 15 participating countries are expected to have operational national genomic infrastructure nodes. The Genome of Europe project launched in 2024 targets whole genome sequencing of over 100,000 citizens.
UK Biobank is the world's largest single-nation biomedical database, enrolling 500,000 volunteer participants between 2006 and 2010. In 2023, whole genome sequencing of all 500,000 participants was completed and released publicly, making it the largest WGS dataset ever produced. The resource now exceeds 30 petabytes of genomic, imaging, and health data. UK Biobank approved GBP 127.6 million in 2023 for a new state-of-the-art facility.
Genomics England, established in 2013 and wholly owned by the Department of Health and Social Care, executed the 100,000 Genomes Project, sequencing over 85,000 participants by December 2018. The project reported 18.5% clinically actionable findings. Now expanding via the Generation Study, which aims to sequence 100,000 newborn genomes. Operates within a broader GBP 5 billion government R&D investment package.
CODIS is the backbone of forensic DNA identification in the United States and the largest operational forensic DNA database in the world. Over 14 million offender profiles, 4 million arrestee profiles, and 1 million forensic profiles. CODIS has aided more than 520,000 criminal investigations. The software is used by over 90 international laboratories across 50 countries. Since 2020, DHS has collected approximately 2.6 million immigration-related DNA profiles.
The All of Us Research Program, launched in 2015 under the Precision Medicine Initiative, is a National Institutes of Health effort to sequence and collect health data from 1 million or more participants. Approximately 297,549 volunteers enrolled. Over 80% from communities historically underrepresented in biomedical research. Published its first major genomic dataset in Nature in 2024.
The Saudi Human Genome Program, launched in 2013 by KACST, aims to sequence the Saudi population at scale. Over 100,000 Saudi genomes sequenced as of 2024. SHGP operates under Saudi Vision 2030 as a strategic infrastructure investment in precision medicine and population health. Plans to expand sequencing to millions of citizens with heavy investment in sequencing facilities and bioinformatics centers.
France launched the Plan France Medecine Genomique 2025 in 2016 with a EUR 670 million budget, one of the largest single-country genomic medicine investments in Europe. The plan calls for 12 high-throughput sequencing platforms distributed nationally, with a target of 235,000 whole genome sequences per year. Two pilot platforms (SeqOIA in Paris and AURAGEN in Lyon) operational by 2020.
Japan operates two major population genomic programs. ToMMo, established in 2012, has enrolled over 150,000 participants and completed WGS of more than 50,000 at 30x coverage. BioBank Japan, initiated in 2003, has collected DNA and clinical data from over 260,000 patients across 51 diseases. Together, these provide Japan with the most comprehensive Asian genomic reference infrastructure in existence.
Germany launched genomDE as its national strategy for integrating genomic medicine into the healthcare system. The initiative coordinates sequencing centers, bioinformatics infrastructure, and clinical genomics across 16 federal states. Germany participates as a core node in the EU GDI project. The Federal Ministry of Health committed to building national-scale sequencing capacity aligned with the EU 1+MG initiative.
Italy has invested over EUR 200 million in genomic medicine infrastructure. Italy participates in the EU 1+MG initiative and serves as a node in the GDI project. Italian hospitals and research institutions have sequenced tens of thousands of genomes across rare disease and oncology programs. The Italian National Health Service is integrating genomic data into clinical pathways.
Genome Canada, established in 2000, has channeled over CAD 1.6 billion in federal funding into genomics research and infrastructure across the country. Six regional genome centers fund large-scale sequencing projects. The All For One (AFO) health initiative aims to build a pan-Canadian genomic data infrastructure for precision health. Provincial programs in BC, Ontario, and Quebec complement federal investments.
Across the Gulf Cooperation Council, national genome initiatives are scaling population sequencing, precision medicine infrastructure, and sovereign reference databases. These programs are building regional sequencing capacity, bioinformatics centers, and long-horizon public health datasets designed for national deployment.
Combined public investment across these programs
Millions of genomes are being sequenced. Petabytes of data are being generated. All of these programs face the same problem: how to turn terabytes of raw sequencing data into a deployable, searchable, sovereign system.
That is what Aveum GIS does. One extraction. One identifier. Sub-second. At national scale.
Die Welt bewegt sich.